(1R,5S)-11-(3-Methyl-8-((3-pyrrolidin-1-yl)propyl)amino)-[1,2,4]-triazolo[4,3-b]pyridazine-6-carbonyl)-2,3,5,6-tetrahydro-1,5-epiminobenzo[d]azocin-4(1H)-one

ID: ALA5086059

PubChem CID: 166634222

Max Phase: Preclinical

Molecular Formula: C25H30N8O2

Molecular Weight: 474.57

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nnc2c(NCCCN3CCCC3)cc(C(=O)N3[C@H]4Cc5ccccc5[C@@H]3CNC4=O)nn12

Standard InChI:  InChI=1S/C25H30N8O2/c1-16-28-29-23-19(26-9-6-12-31-10-4-5-11-31)14-20(30-33(16)23)25(35)32-21-13-17-7-2-3-8-18(17)22(32)15-27-24(21)34/h2-3,7-8,14,21-22,26H,4-6,9-13,15H2,1H3,(H,27,34)/t21-,22-/m0/s1

Standard InChI Key:  KJDAPEOBMGLZBI-VXKWHMMOSA-N

Molfile:  

 
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
   -3.3182    2.7471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6036    3.1594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8918    2.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8918    1.9223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6019    1.5105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3182    1.9186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3110    1.3415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4860    1.3415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0945    1.9223    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0945    2.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4860    3.3280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3112    3.3280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7432    2.3781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2330    1.4350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5917    1.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6455    0.7206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2723    4.1251    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.8092    3.1600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0256    0.9292    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2331    0.0057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6452   -0.7062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4705   -0.7062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8825    0.0040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4742    0.7206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6852   -0.1680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0188   -1.3173    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7696   -0.9847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2326   -1.4208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2687    0.4154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5925   -1.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0051   -2.1355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8303   -2.1355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2429   -2.8501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0680   -2.8501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3182   -3.6543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6646   -4.1251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9970   -3.6330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
  3 12  1  0
 11 12  1  0
 11 13  1  0
  7 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 11 17  1  6
 10 18  2  0
  7 19  1  6
 20 16  1  0
 21 20  2  0
 22 21  1  0
 23 22  1  0
 24 23  1  0
 16 24  2  0
 23 25  1  0
 22 26  2  0
 26 27  1  0
 27 25  2  0
 21 28  1  0
 25 29  1  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 34 33  1  0
 34 35  1  0
 35 36  1  0
 37 36  1  0
 33 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5086059

    ---

Associated Targets(Human)

ATAD2 Tchem ATPase family AAA domain-containing protein 2 (598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 474.57Molecular Weight (Monoisotopic): 474.2492AlogP: 1.57#Rotatable Bonds: 6
Polar Surface Area: 107.76Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.44CX Basic pKa: 9.46CX LogP: 0.22CX LogD: -1.83
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.52Np Likeness Score: -1.16

References

1. Winter-Holt JJ, Bardelle C, Chiarparin E, Dale IL, Davey PRJ, Davies NL, Denz C, Fillery SM, Guérot CM, Han F, Hughes SJ, Kulkarni M, Liu Z, Milbradt A, Moss TA, Niu H, Patel J, Rabow AA, Schimpl M, Shi J, Sun D, Yang D, Guichard S..  (2022)  Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models.,  65  (4.0): [PMID:35133824] [10.1021/acs.jmedchem.1c01871]

Source